183 related articles for article (PubMed ID: 26899498)
21. Peptide action in stroke therapy.
Aarts MM; Tymianski M
Expert Opin Biol Ther; 2003 Oct; 3(7):1093-104. PubMed ID: 14519074
[TBL] [Abstract][Full Text] [Related]
22. AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid.
Meade AJ; Meloni BP; Mastaglia FL; Watt PM; Knuckey NW
Brain Res; 2010 Nov; 1360():8-16. PubMed ID: 20833150
[TBL] [Abstract][Full Text] [Related]
23. Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets.
Hu HJ; Song M
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2706-2719. PubMed ID: 29054733
[TBL] [Abstract][Full Text] [Related]
24. Chloride co-transporters as possible therapeutic targets for stroke.
Martín-Aragón Baudel MA; Poole AV; Darlison MG
J Neurochem; 2017 Jan; 140(2):195-209. PubMed ID: 27861901
[TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.
Luchtman D; Gollan R; Ellwardt E; Birkenstock J; Robohm K; Siffrin V; Zipp F
J Neurochem; 2016 Mar; 136(5):971-80. PubMed ID: 26662167
[TBL] [Abstract][Full Text] [Related]
26. A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity.
Hossain MI; Roulston CL; Kamaruddin MA; Chu PWY; Ng DCH; Dusting GJ; Bjorge JD; Williamson NA; Fujita DJ; Cheung SN; Chan TO; Hill AF; Cheng HC
J Biol Chem; 2013 Apr; 288(14):9696-9709. PubMed ID: 23400779
[TBL] [Abstract][Full Text] [Related]
27. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacology of neuroprotection in acute ischemic stroke].
Fernández-Gómez FJ; Hernández F; Argandoña L; Galindo MF; Segura T; Jordán J
Rev Neurol; 2008 Sep 1-15; 47(5):253-60. PubMed ID: 18780272
[TBL] [Abstract][Full Text] [Related]
29. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.
Mattson MP
Neuromolecular Med; 2003; 3(2):65-94. PubMed ID: 12728191
[TBL] [Abstract][Full Text] [Related]
30. PBT2 inhibits glutamate-induced excitotoxicity in neurons through metal-mediated preconditioning.
Johanssen T; Suphantarida N; Donnelly PS; Liu XM; Petrou S; Hill AF; Barnham KJ
Neurobiol Dis; 2015 Sep; 81():176-85. PubMed ID: 25697105
[TBL] [Abstract][Full Text] [Related]
31. Post-injury administration of a combination of memantine and 17β-estradiol is protective in a rat model of traumatic brain injury.
Day NL; Carle MS; Floyd CL
Neurochem Int; 2017 Dec; 111():57-68. PubMed ID: 28472639
[TBL] [Abstract][Full Text] [Related]
32. Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.
Lee ST; Chu K; Park JE; Kang L; Ko SY; Jung KH; Kim M
Brain Res; 2006 Nov; 1118(1):199-207. PubMed ID: 16959224
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
Domin H; Jantas D; Śmiałowska M
Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
[TBL] [Abstract][Full Text] [Related]
34. Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy.
Khan M; Dhammu TS; Matsuda F; Singh AK; Singh I
BMC Neurosci; 2015 Jul; 16():42. PubMed ID: 26174015
[TBL] [Abstract][Full Text] [Related]
35. Tat-NR2B9c prevents excitotoxic neuronal superoxide production.
Chen Y; Brennan-Minnella AM; Sheth S; El-Benna J; Swanson RA
J Cereb Blood Flow Metab; 2015 May; 35(5):739-42. PubMed ID: 25669908
[TBL] [Abstract][Full Text] [Related]
36. Calmodulin kinase IV-dependent CREB activation is required for neuroprotection via NMDA receptor-PSD95 disruption.
Bell KF; Bent RJ; Meese-Tamuri S; Ali A; Forder JP; Aarts MM
J Neurochem; 2013 Jul; 126(2):274-87. PubMed ID: 23363435
[TBL] [Abstract][Full Text] [Related]
37. Tinospora cordifolia as a potential neuroregenerative candidate against glutamate induced excitotoxicity: an in vitro perspective.
Sharma A; Kaur G
BMC Complement Altern Med; 2018 Oct; 18(1):268. PubMed ID: 30285727
[TBL] [Abstract][Full Text] [Related]
38. Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke.
Shen Z; Xiang M; Chen C; Ding F; Wang Y; Shang C; Xin L; Zhang Y; Cui X
Biomed Pharmacother; 2022 Jul; 151():113125. PubMed ID: 35609367
[TBL] [Abstract][Full Text] [Related]
39. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95.
Fan J; Vasuta OC; Zhang LY; Wang L; George A; Raymond LA
J Neurochem; 2010 Nov; 115(4):1045-56. PubMed ID: 20831617
[TBL] [Abstract][Full Text] [Related]
40. Activation of a novel injury-induced calcium-permeable channel that plays a key role in causing extended neuronal depolarization and initiating neuronal death in excitotoxic neuronal injury.
Deshpande LS; Limbrick DD; Sombati S; DeLorenzo RJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):443-52. PubMed ID: 17483292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
